Mapmygenome India Profile
Key Indicators
- Authorised Capital ₹ 13.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 2.95 Cr
as on 17-07-2024
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.14 Cr
as on 17-07-2024
- Satisfied Charges ₹ 5.52 Cr
as on 17-07-2024
- Revenue -76.43%
(FY 2023)
- Profit -167.62%
(FY 2023)
- Ebitda -137.61%
(FY 2023)
- Net Worth -61.03%
(FY 2023)
- Total Assets 32.46%
(FY 2023)
About Mapmygenome India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 13.00 Cr and a paid-up capital of Rs 2.95 Cr.
The company currently has active open charges totaling ₹9.14 Cr. The company has closed loans amounting to ₹5.52 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ramabadran Gopalakrishnan, Venkata Lingareddy, Anuradha Acharya, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232TG2012PLC079091
- Company No.
079091
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Feb 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Mapmygenome India Limited offer?
Mapmygenome India Limited offers a wide range of products and services, including Medical Test Services, Sequencing Analysis Services, Medical Laboratory Instruments, Pathology Lab Equipments, Diagnostic Imaging & Pathology Labs, DNA Testing Service, Genetic Testing.
Who are the key members and board of directors at Mapmygenome India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramabadran Gopalakrishnan  | Director | 01-Feb-2017 | Current |
Arjun Malhotra  | Director | 16-Apr-2013 | Current |
| Venkata Lingareddy | Additional Director | 06-Apr-2024 | Current |
| Anuradha Acharya | Director | 20-Apr-2013 | Current |
Financial Performance and Corporate Structure Insights of Mapmygenome India.
Mapmygenome India Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 76.43% decrease. The company also saw a substantial fall in profitability, with a 167.62% decrease in profit. The company's net worth observed a substantial decline by a decrease of 61.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mapmygenome India?
In 2023, Mapmygenome India had a promoter holding of 74.74% and a public holding of 25.26%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 May 2023 | ₹9.49 M | Open |
Hdfc Bank Limited Creation Date: 13 Jan 2023 | ₹8.00 Cr | Open |
Canara Bank Creation Date: 10 Oct 2022 | ₹0.20 M | Open |
How Many Employees Work at Mapmygenome India?
Mapmygenome India has a workforce of 87 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mapmygenome India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mapmygenome India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
